Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
BCAB BioAtla
- 1.450
- +0.020+1.40%
Close Dec 13 16:00 ET
- 1.430
- -0.020-1.38%
Post 19:32 ET
70.10MMarket Cap-0.85P/E (TTM)
1.490High1.415Low305.06KVolume1.460Open1.430Pre Close442.12KTurnover0.88%Turnover RatioLossP/E (Static)48.35MShares4.02052wk High3.05P/B50.48MFloat Cap1.14052wk Low--Dividend TTM34.82MShs Float76.630Historical High--Div YieldTTM5.25%Amplitude1.140Historical Low1.449Avg Price1Lot Size
About BioAtla Company
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay M. Short,PhD
- Chairman of the Board and Chief Executive Officer
- 3.30M
- Richard A. Waldron
- Senior Vice President and Chief Financial Officer
- 1.24M
- Dr. Eric Sievers, M.D.
- Chief Medical Officer
- 1.32M
- Christian Vasquez
- Chief Accounting Officer, Controller and Corporate Secretary
- --
- Scott A. Smith
- Director
- 1.27M
- Sylvia McBrinn
- Independent Director
- 164.57K
- Dr. Susan Moran, M.D.
- Independent Director
- 158.19K
- Dr. Lawrence J. Steinman, M.D.
- Independent Director
- 161.19K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 180.44K
- Edward Williams
- Independent Director
- 168.94K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.